ROST
68
-4
EXPD
35
-2
PNC
75
3
XRX
34
-3
HRL
36
-2
ROP
41
-7
HPQ
46
2
MAR
48
-5
NAVI
19
-13
NRG
55
3
GS
76
3
JPM
60
-9
ZTS
8
-2
VZ
34
-8
AMGN
23
-3
LEN
32
-4
ORLY
41
-7
DIS
62
-2
FRT
53
3
NEM
63
6
ROST
68
-4
EXPD
35
-2
PNC
75
3
XRX
34
-3
HRL
36
-2
ROP
41
-7
HPQ
46
2
MAR
48
-5
NAVI
19
-13
NRG
55
3
GS
76
3
JPM
60
-9
ZTS
8
-2
VZ
34
-8
AMGN
23
-3
LEN
32
-4
ORLY
41
-7
DIS
62
-2
FRT
53
3
NEM
63
6
Financhill
Back

First Trust Large Cap Growth AlphaDEX Fund Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
75

FTC
First Trust Large Cap Growth AlphaDEX Fund

Last Price:
$162.03
Seasonality Move:
4.93%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Buy
75
First Trust Large Cap Growth AlphaDEX Fund (FTC) is a Buy

Is First Trust Large Cap Growth AlphaDEX Fund a Buy, Sell or Hold?

  • The current First Trust Large Cap Growth AlphaDEX Fund [FTC] share price is $160.80. The Score for FTC is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • FTC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

FTC Stock Price Chart

What is First Trust Large Cap Growth AlphaDEX Fund's stock price today?

  • The First Trust Large Cap Growth AlphaDEX Fund share price today is $160.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FTC is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

FTC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 55.41 Buy
Chaikin Money Flow: -6518 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (154.69 - 161.55) Buy
Bollinger Bands (100): (155.18 - 161.6) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

FTC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 160.19 Buy
20-day SMA: 157.53 Buy
50-day SMA: 159.76 Buy
200-day SMA: 148.5 Buy
8-day EMA: 159.9 Buy
20-day EMA: 158.91 Buy
50-day EMA: 155.22 Buy
200-day EMA: 96.22 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

First Trust Large Cap Growth AlphaDEX Fund Earnings Growth & FTC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

First Trust Large Cap Growth AlphaDEX Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):